Indications and uses
for temporary relief of minor aches and pains due to: headache backache muscular aches arthritis pain colds flu fever toothache premenstrual and menstrual cramps Temporarily relieves runny nose sneezing itchy nose and throat
for temporary relief of minor aches and pains due to: headache backache muscular aches arthritis pain colds flu fever toothache premenstrual and menstrual cramps Temporarily relieves runny nose sneezing itchy nose and throat
Adults and children 12 years of age and older: take 2 caplets every 6 hours. Maximum daily dose is 6 tablets. Children under 12 years of age: ask a doctor.
Drug Facts
Acetaminophen 500 mg
Pain reliever/fever reducer
Diphenhydramine HCl 12.5 mg
Antihistamine
for temporary relief of minor aches and pains due to:
Temporarily relieves
Liver Warning: This product contains acetaminophen. Severe liver damage may occur if you take:
Allergy Alert: Acetaminophen may cause severe skin reactions. Symptoms may include:
If a skin reaction occurs, stop use and seek medical help right away.
These may be signs of a serious condition.
ask a health professional before use.
Overdose warning: Taking more than the recommended dose (overdose) could cause serious health problems, including liver damage. In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away. Prompt medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.
Do not exceed recommended dosage.
Adults and children 12 years of age and older: take 2 caplets every 6 hours. Maximum daily dose is 6 tablets. Children under 12 years of age: ask a doctor.
croscarmellose sodium, FD&C yellow no. 6 lake, hypromellose, magnesium stearate, microcrystalline cellulose, mineral oil, polyvinylpyrrolidone, silica, sodium carboxymethyl starch, starch, stearic acid, talc, titanium dioxide, triacetin
1-800-443-4908
EXTRA STRENGTH
Percogesic®
Acetaminophen/
Diphenhydramine
Fever Reducer/ Antihistamine
40 COATED CAPLETS
| Class | Version | Type | Effective |
|---|---|---|---|
| DIPHENHYDRAMINE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63029-054-40 | PercogesicExtra Strength | 1 in 1 CARTON | CAPSULE, COATED | 1 | 1 | |
| 63029-054-40 | PercogesicExtra Strength | 40 in 1 BOTTLE, PLASTIC | CAPSULE, COATED | 40 | 1 | |
| 63029-054-60 | PercogesicExtra Strength | 1 in 1 CARTON | CAPSULE, COATED | 1 | 1 | |
| 63029-054-60 | PercogesicExtra Strength | 60 in 1 BOTTLE, PLASTIC | CAPSULE, COATED | 60 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 63029-054 | 63029-054-60, 63029-054-40 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ACETAMINOPHEN | 362O9ITL9D | ACTIB |
| DIPHENHYDRAMINE | 8GTS82S83M | ACTIB |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| FD&C YELLOW NO. 6 | H77VEI93A8 | IACT |
| HYPROMELLOSES | 3NXW29V3WO | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
| MINERAL OIL | T5L8T28FGP | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| SODIUM STARCH GLYCOLATE TYPE A | H8AV0SQX4D | IACT |
| STEARIC ACID | 4ELV7Z65AP | IACT |
| TALC | 7SEV7J4R1U | IACT |
| TITANIUM DIOXIDE | 15FIX9V2JP | IACT |
| TRIACETIN | XHX3C3X673 | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Percogesic Extra Strength | ACETAMINOPHEN AND DIPHENHYDRAMINE | Medtech Products Inc. | 2c5f1140-fb83-42c9-b0b1-5e2bd69340bb | 2024-02-01 | Warnings | 63029-054-60 63029-054-40 63029-054 63029005460 63029005440 dd068345-eb74-40b1-80b5-ef9df6fde1cd 2c5f1140-fb83-42c9-b0b1-5e2bd69340bb |
Adverse event summaries are temporarily unavailable. Other product information remains available.